| 000 | 01675 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513092341.0 | ||
| 264 | 0 | _c19960820 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi960190j _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Donk, W A | |
| 245 | 0 | 0 |
_aInactivation of ribonucleotide reductase by (E)-2'-fluoromethylene-2'-deoxycytidine 5'-diphosphate: a paradigm for nucleotide mechanism-based inhibitors. _h[electronic resource] |
| 260 |
_bBiochemistry _cJun 1996 |
||
| 300 |
_a8381-91 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAlkylation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aDeoxycytosine Nucleotides _xpharmacology |
| 650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 | _aIsomerism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPigments, Biological |
| 650 | 0 | 4 |
_aRibonucleotide Reductases _xantagonists & inhibitors |
| 700 | 1 | _aYu, G | |
| 700 | 1 | _aSilva, D J | |
| 700 | 1 | _aStubbe, J | |
| 700 | 1 | _aMcCarthy, J R | |
| 700 | 1 | _aJarvi, E T | |
| 700 | 1 | _aMatthews, D P | |
| 700 | 1 | _aResvick, R J | |
| 700 | 1 | _aWagner, E | |
| 773 | 0 |
_tBiochemistry _gvol. 35 _gno. 25 _gp. 8381-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi960190j _zAvailable from publisher's website |
| 999 |
_c8677423 _d8677423 |
||